CJC-1295 + Ipamorelin — pre-combined dual peptide blend targeting complementary GH secretion pathways. GHRH receptor agonist + GHS-R1a agonist in one vial. 5mg blend, HPLC verified per peptide.
The CJC-1295 + Ipamorelin blend combines two distinct growth hormone-stimulating peptides in a single lyophilized vial: CJC-1295 with DAC (a GHRH receptor agonist) and Ipamorelin (a GHS-R1a agonist). These two compounds target complementary and synergistic pathways of GH stimulation — the hypothalamic GHRH axis and the ghrelin receptor pathway.
Researchers use this blend to study the combined pharmacological effects of simultaneous GHRH receptor and GHS-R1a activation — a research paradigm that mirrors the natural pulsatile GH secretion mechanism more closely than either compound alone. Each peptide in the blend is independently tested and documented.
For a full breakdown of the research literature, read our CJC-1295 + Ipamorelin research guide →
CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.
Everything you need to evaluate this compound for your research protocol.
| Specification | Value |
|---|---|
| Blend | CJC-1295 with DAC + Ipamorelin |
| CJC-1295 Class | Tetrasubstituted GHRH analog with Drug Affinity Complex |
| Ipamorelin Class | Pentapeptide GHS-R1a agonist |
| Form | Lyophilized powder (pre-combined) |
| Purity | ≥98% per component by reversed-phase HPLC |
| Identity | Each peptide confirmed by mass spectrometry |
| Storage (lyophilized) | −20°C, protected from light and moisture. Stable 24+ months. |
| Reconstitution | Bacteriostatic water — both peptides dissolve together |
| Documentation | Lot-specific COA with per-peptide HPLC chromatograms — included with every order |
All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for CJC-1295 + Ipamorelin. Here’s where the science currently stands.
Laferrère B. et al. (2005) J Clin Endocrinol Metab 90(5):2526-32
Popovic V. et al. (2003) J Clin Endocrinol Metab 88(7):3149-54
Smith RG. et al. (2005) Endocrinology 146(6):2510-6
Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.
In stock. COA included. HPLC + mass spec verified. Ships with full documentation.
For laboratory research use only. Not for human or animal consumption.
CoreVionRX supplies research compounds to qualified laboratories and research institutions.
Documentation & Testing Standards
Every batch is independently tested before release. Research peptide FAQs · CoreVionRX testing standards
Related Research Compounds